BrightEdge - American Cancer Society
Description
BrightEdge - American Cancer Society focuses on investing in cancer-focussed therapies and technologies.
Investor Profile
BrightEdge - American Cancer Society has backed more than 6 startups, with 4 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Pre Seed, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Therapeutics, Medical.
Stage Focus
- Seed (50%)
- Pre Seed (17%)
- Series C (17%)
- Series Unknown (17%)
Country Focus
- United States (83%)
- United Kingdom (17%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Therapeutics
- Medical
- Life Science
- Health Diagnostics
- Health Care
- Wellness
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
